source
- Abivax’s ulcerative colitis Phase 3 trial shows promising efficacy but cancer cases raise safety concernsAbivax announced that its Phase 3 maintenance trial in ulcerative colitis produced results it called “landmark,” showing the drug’s ability to keep patients in remission. The company emphasized th…
- US-made packaging equipment offers faster lead times and regulatory alignment for pharma manufacturersAs pharma firms upgrade their packaging lines, the source of the equipment is becoming a strategic factor rather than a simple purchasing decision. Domestic production shortens lead times and redu…